The heme biosynthetic pathway of the malaria parasite is a drug target and the import of host ␦-aminolevulinate dehydratase (ALAD), the second enzyme of the pathway, from the red cell cytoplasm by the intra erythrocytic malaria parasite has been demonstrated earlier in this laboratory. In this study, ALAD encoded by the Plasmodium falciparum genome (PfALAD) has been cloned, the protein overexpressed in Escherichia coli, and then characterized. The mature recombinant enzyme (rPfALAD) is enzymatically active and behaves as an octamer with a subunit M r of 46,000. The enzyme has an alkaline pH optimum of 8.0 to 9.0. rPfALAD does not require any metal ion for activity, although it is stimulated by 20 -30% upon addition of Mg 2؉ . The enzyme is inhibited by Zn 2؉ and succinylacetone. The presence of PfALAD in P. falciparum can be demonstrated by Western blot analysis and immunoelectron microscopy. The enzyme has been localized to the apicoplast of the malaria parasite. Homology modeling studies reveal that PfALAD is very similar to the enzyme species from Pseudomonas aeruginosa, but manifests features that are unique and different from plant ALADs as well as from those of the bacterium. It is concluded that PfALAD, while resembling plant ALADs in terms of its alkaline pH optimum and apicoplast localization, differs in its Mg 2؉ independence for catalytic activity or octamer stabilization. Expression levels of PfALAD in P. falciparum, based on Western blot analysis, immunoelectron microscopy, and EDTA-resistant enzyme activity assay reveals that it may account for about 10% of the total ALAD activity in the parasite, the rest being accounted for by the host enzyme imported by the parasite. It is proposed that the role of PfALAD may be confined to heme synthesis in the apicoplast that may not account for the total de novo heme biosynthesis in the parasite.
Studies in this laboratory had demonstrated that the malaria parasites (Plasmodium falciparum and Plasmodium berghei) are capable of heme biosynthesis de novo, despite acquiring large amounts of heme from the host red cell hemoglobin in the intraerythrocytic stage (1, 2) . Inhibition of the de novo heme biosynthetic pathway leads to death of the parasite and the pathway is therefore a drug target (1) (2) (3) . Studies on the enzymes of the heme-biosynthetic pathway have revealed that the first enzyme, ␦-aminolevulinate synthase, is coded for by the parasite genome and is localized in the parasite mitochondrion (4, 5) . Studies from this laboratory have shown that the second enzyme of the pathway, ␦-aminolevulinate dehydratase (ALAD), 1 in the parasite is of host origin and evidence was provided to show that the enzyme is translocated (imported) from the host red cell into the parasite and is functional (2, 3) .
At the same time genome sequence data available for P. falciparum indicates that the parasite genome codes for ALAD (PfALAD) and other enzymes of the heme-biosynthetic pathway. Sato et al. (6) have shown by phylogenetic amino acid sequence analysis derived from truncated cDNA, including the metal-cofactor binding region and the active site, that PfALAD is more closely related to the Mg 2ϩ -binding enzyme species from plant and algal plastids than the Zn 2ϩ -binding species from animals and fungi. Subsequently, Sato and Wilson (7) have shown that the full-length PfALAD cDNA can complement a hemB mutant (ALAD Ϫ/Ϫ ) of Escherichia coli, indicating that the cDNA codes for a functional enzyme. These workers have also predicted the following. 1) PfALAD probably requires Mg 2ϩ as a cofactor, although the metal ion may not serve as an allosteric activator. 2) It is possible that the intrinsic PfALAD is responsible for de novo heme synthesis in the parasite rather than the imported host enzyme.
It is therefore of interest to study the PfALAD in detail experimentally. In the present study, parasite gene-coded PfALAD-cDNA has been cloned and expressed in E. coli. The properties of the purified recombinant enzyme have been studied in detail, especially its metal ion requirement for activity. The enzyme has been modeled to explain some of its unique properties. It has been possible to raise antibodies that specifically interact with PfALAD and with these antibodies the localization of the enzyme in P. falciparum in culture has been studied by Western blot analysis and immunoelectron microscopy. Finally, based on studies on catalytic activity, inhibitor sensitivity, and localization of PfALAD, an assessment of the contribution of PfALAD to the total ALAD activity of the parasite in relation to the contribution of the imported host enzyme has been made.
EXPERIMENTAL PROCEDURES
Materials-Full-length mouse erythroid ALAD-cDNA clone was a kind gift from Dr. Terry Bishop, Johns Hopkins University, Baltimore, MD. Anti-mouse and anti-rabbit secondary antibodies were purchased from Invitrogen (ALP conjugates) or Pelco International (gold conjugates). All other chemicals were obtained from either Sigma or Invitrogen.
Parasite Maintenance and Isolation-P. falciparum culture was maintained on human O ϩ red blood cells by the candle jar method (8) . The cells were pelleted down and the parasites, essentially at the trophozoite stage, were isolated by treatment with 0.15% (w/v) saponin (9) or osmotic lysis (10) with slight modifications. For the latter procedure, packed infected erythrocytes were treated with 40 volumes of cold 10 mM potassium phosphate buffer, pH 7.4, mixed thoroughly and allowed to stand on ice for 10 min. The released parasites following lysis of the red cells were pelleted down and washed once again with the same buffer. The parasite pellet was subsequently washed three times with phosphate-buffered saline. With both procedures, the final washes were tested for possible hemoglobin or erythroid ALAD presence and were found to be undetectable.
Cloning of PfALAD cDNA-The full-length cDNA (cDNA-1) sequence of PfALAD was obtained from the genome data base and the sequence provided by Sato and Wilson (7) . Reverse transcriptase-PCR amplification was carried out using the primer pair, PfALAD-1 (5Ј-ATGT-TAAAATCAGATGTAGTGC-3Ј) and PfALAD-5 (5Ј-TCATAGAGTT-AATTCAATATTTAAA-3Ј) to give a 1356-bp fragment (1-451 amino acids). A second cDNA (cDNA-2) was obtained using the primer pair, PfALAD-2 (5Ј-AATTCACAAATATTAAGTAAAATGAA-3Ј) and PfALAD-5 to give a 1191-bp fragment (56 -451 amino acids). A third cDNA (cDNA-3) was obtained using the primer pair PfALAD-3 (5Ј-CACAAATATAAAGACATCGAAACTT-3Ј) and PfALAD-4 (5Ј-TCATC-CCCCTCTATAATATGTTTATCCA-3Ј) to give a 675-bp product (115-340 amino acids) (Fig. 1, A-C) . Because the primers were designed with EcoRI/BamHI linkers, all cDNAs (cDNA-1, -2, and -3) were cloned into pRSET vectors (Invitrogen, CA) at the BamHI-EcoRI site and proteins were expressed in E. coli BL21(DE3) after isopropyl-1-thio-␤-D-galactopyranoside induction. Whereas the expression of cDNA-1 was very poor, cDNA-2 (56 -451 aa) and cDNA-3 (115-340 aa) could be expressed in pRSET A vector. cDNA-2 was also cloned into PGEX4T1 vector to express the protein as GST fusion. In both cases, the E. coli cells were initially grown to an A 600 of 1 at 30°C with constant shaking at 200 rpm. The culture was then shifted to 18°C and shaken at 150 rpm for 30 min before isopropyl-1-thio-␤-D-galactopyranoside (0.5 mM) addition. Induction was carried out for 15 h. These conditions resulted in cDNA-2 being expressed in the soluble phase. In the case of His-tagged protein the frozen E. coli cells were lysed in lysis buffer (50 mM Tris buffer, pH 8.5) by sonication. The supernatant after centrifugation (20,000 rpm for 30 min) was subjected to ammonium sulfate fractionation (0 -35%). The pellet was resuspended in 50 mM Tris, pH 8.5, containing 300 mM KCl and bound to nickel-agarose (Qiagen). After washing the column with equilibration buffer and the buffer containing 0.1% Triton X-100 (w/v) and 30 mM imidazole, the bound protein was eluted with a 30 -300 mM imidazole gradient in the same buffer containing 0.1% Triton X-100. The peak fractions containing the protein were pooled, dialyzed against 50 mM Tris, pH 8.5, containing 20% glycerol, and stored at Ϫ20°C.
In the case of the GST fusion protein, the recombinant E. coli lysate obtained with 50 mM Tris, pH 8.5, containing 0.5% Triton X-100 was centrifuged and the supernatant was directly loaded onto GST-agarose (Sigma) and washed with the same buffer containing 300 mM KCl. The protein was eluted with 50 mM Tris, pH 8.5, containing 30 mM GSH. The peak fractions were pooled and incubated with thrombin for 15 h at 4°C to cleave the GST. The protein was purified on a Superdex-200 gel filtration column and equilibrated with 50 mM Tris, pH 8.5, containing 300 mM KCl using AKTA purifier (Amersham Biosciences). The fractions containing the enzyme were pooled and concentrated by ultrafiltration using a 50-kDa cut-off membrane (VivaScience). cDNA-3 (115-340 aa) was also expressed with histidine tag, but the protein was present in inclusion bodies. It was solubilized using 8 M urea and purified using the nickel-agarose column. The urea was dialyzed out after the protein was eluted from the column. cDNA-2 (56 -451 aa) expressed with histidine tag or as a GST fusion protein (before and after removal of GST) was enzymatically active and was used as the source of the recombinant PfALAD (rPfALAD) in this study. The product of cDNA-3 (115-340 aa) expression is referred to as rPf⌬ALAD in this study and was used to obtain PfALAD-specific antibodies.
Native human ALAD was purified from human red blood cells by a slight modification of the known procedure (11) . Briefly, the soluble red cell supernatant was subjected to DEAE-Sephacel chromatography, ammonium sulfate fractionation (0 -45%), octyl-Sepharose and phenylSepharose chromatography. The last two chromatography steps were repeated to obtain a pure preparation and this was used to raise antibodies to the host ALAD. Recombinant mouse ALAD (rmALAD) was purified as a protein with histidine tag from the clone (gift) and used to study the properties in comparison with rPfALAD. The mammalian enzyme species are highly conserved (12) and the properties of the mouse and human enzymes are very similar.
Enzyme Assay-ALAD enzyme activity was assayed in a total volume of 0.1 ml in a mixture containing 25 mM Trizma (Tris base) (to cover the pH range 7 to 9). Routine assays were carried out at pH 7.5 (25 mM PIPES) and 8.5 (25 mM Tris), in the presence of 5 mM ALA, 5 mM ␤-mercaptoethanol, and enzyme (0.5 to 2.0 g of recombinant proteins or 150 -200 g of protein of parasite extract). The mixture was incubated at 37°C for 1 h and the porphobilinogen (PBG) formed was estimated using modified Ehrlich reagent (13) . No buffer ion effect as such on enzyme activity was seen. While studying the effects of EDTA or o-phenanthroline, the enzymes were first incubated with the chelator for 20 -30 min before the addition of metal ions and ALA. A molar extinction coefficient for PBG of 60,200 M Ϫ1 cm Ϫ1 was used to quantitate PBG concentration. The specific activity of rmALAD ranged mostly between 22 and 26 mol of PBG/mg of protein/h at pH 7.5. The corresponding values for rPfALAD ranged between 3 and 4 mol of PBG/mg of protein/h at pH 8.5 and 2-2.5 mol of PBG/mg of protein/h at pH 7.5.
Determination of Mg 2ϩ
Binding by Atomic Absorption-Metal ion stoichiometry was determined by atomic absorption using a Thermo Jarrell Ash Video 11E aa/ae spectrometer. Purified rPfALAD (5 ml, 400 g of protein/ml), isolated with a histidine tag, was dialyzed against 500 ml of Tris buffer (100 mM, pH 8.5) containing 20% glycerol with three changes at 4-h intervals. The enzymatically active preparation was used to measure the intrinsic Mg 2ϩ content. PfALAD Homology Modeling-Alignment of the sequence (accession number CAC82990/Q8MYK5) of PfALAD with the sequence neighbors identified by a BLAST (14) search of the Non-Redundant and Protein Data Bank (15) data bases, indicated ALAD from P. aeruginosa (PsALAD, Protein Data Bank codes 1B4K and 1GZG) (16, 17) to be the closest structural template with sequence similarities of 56% (E value: 3e Ϫ50 ) over 330 amino acid residues. The alignment with the template, when carefully verified by examining additional pairwise (18) and multiple alignments (19) with other closely related sequences, indicated a few local frameshifts as judged by the position of well conserved known functional residues, which were then corrected by minor editing. The model of the mature polypeptide of a subunit was built using Insight-II (Accelrys Inc.) using homology modeling protocols. The few insertions in the PfALAD were built using the distance matrix-based loop searching method available in Insight-II. The model was then soaked in a 5-Å layer of water molecules and energy was minimized initially using a steepest descent algorithm and then with a conjugate gradient minimizer. The octamer of PfALAD was built based on the octamer in PsALAD and the components were energy minimized individually as dimers and tetramers. PfALAD model was also compared with the structure of human erythrocyte ALAD (hALAD, Protein Data Bank code 1E51). Structural comparisons were carried out through a DALI (20) analysis. Various manipulations and analyses were carried out using Insight-II.
Localization of ALAD in P. falciparum-The parasite in culture was used to analyze for host and PfALAD by Western blot analysis and immunoelectron microscopy. For Western blot analysis, purified rPfALAD, partially purified native human ALAD, as well as parasite extracts were subjected to 10% SDS-PAGE and then transferred to nitrocellulose membranes for immunoblot analysis. Duplicate blots were screened with antibodies to the human red cell enzyme and rPf⌬ALAD with antibody dilutions in the range of 1:1000 to 1:2000 followed by goat anti-rabbit (human ALAD) or goat anti-mouse (rPf⌬ALAD) antibodies conjugated to alkaline phosphatase.
For immunoelectron microscopic studies, the parasite-infected red blood cell pellet was washed three times with phosphate-buffered saline and then resuspended in 1% (w/v) paraformaldehyde and 0.2% (w/v) glutaraldehyde in phosphate buffer, pH 7.1, for 3-4 h. Immunostaining was then carried out by the protocol supplied by PELCO International using the LR White resin. Ultrathin sections from the embedded block were mounted on nickel grids. All incubations with antibodies were carried out in blocking buffers containing 2% (w/v) bovine serum albumin. Anti-human ALAD antibodies (rabbit) or anti-rPf⌬ALAD antibodies (mouse) were used at 1:200 dilution and incubated for 2-3 h. Goat anti-rabbit or goat anti-mouse IgG coupled to 10-or 20-nm gold particles were used as secondary antibodies at 1:50 dilution and incubated for 1 h. The grids were then post-fixed with 1% glutaraldehyde in phosphate-buffered saline, washed with distilled water, subjected to silver enhancement, and then counterstained with uranyl acetate in 50% (w/v) ethanol. Sections were viewed using a JOEL CX100 transmission electron microscope.
Other Procedures-RNA was isolated from the parasite using Trizol (Invitrogen, CA). Antibodies were raised to purified native human ALAD in rabbits and to rPf⌬ALAD in mice. The parasite lysate was prepared by resuspending the parasite pellet in 50 mM Tris, pH 8, followed by freeze-thawing and sonication. The sonicate was then incubated with 0.5% Triton X-100 for 30 min in ice to obtain the total ALAD activity in the soluble phase. Partially purified hALAD and rPfALAD were used as controls. The assays were done in the presence or absence of 25 mM EDTA. Human red blood cell lysate was fractionated on a DEAE column to remove hemoglobin and partially purify hALAD.
RESULTS
The full-length cDNA (cDNA-1) for PfALAD was cloned into E. coli but the expression was very poor. This could be because of the hydrophobic signal sequence at the N terminus. Therefore cDNA-2 (56 to 451 aa) that permitted good growth of the E. coli hemB mutant in the complementation assay (7) was cloned into E. coli and expressed as a protein with the histidine tag or as a GST fusion protein (Fig. 2, A and B) . Application of PlasmoAP (21), a rule-based predictor for apicoplast targeting peptides within P. falciparum, revealed that the N-terminal 70 amino acids would encompass the signal and transit peptides necessary to target ALAD to the apicoplast. Therefore, the removal of the N-terminal stretch (1-55 amino acids) should not affect enzyme activity. All the purified rPfALAD preparations, with histidine tag and with or without GST, were enzymatically active. Because, the histidine-tagged protein yields were higher than the GST-cleaved preparation, the former was used in most of the experiments. The purified rPf⌬ALAD (Fig.  2C ) was used to raise PfALAD-specific antibodies.
Oligomeric Nature
Because most ALADs purified so far are octamers (22, 23) , an assessment of the oligomeric state of rPfALAD was made based on the gel filtration profile on a Superdex 200 analytical FPLC column. The results presented in Fig. 3A indicate that the rPfALAD elutes from the column with an M r of 345,000 compared with the value of 335,000 obtained for rmALAD. The subunit M r values for rPfALAD and rmALAD are 46,000 and 38,000 on the basis of mobility on SDS-PAGE (Fig. 3B) . Thus, both ALAD species are octamers.
pH Optimum and K m
Because ALADs from plant sources have an alkaline pH optimum (23) , it was of interest to assess the same with rPfALAD. The results presented in Fig. 4 reveal that rPfALAD indeed has a pH optimum between 8 and 9, whereas rmALAD has a pH optimum between 7.5 and 8.5. The K m value for ALA with rPfALAD is 0.208 mM at pH 8.5, whereas for rmALAD at pH 7.5 the value is 0.294 mM. 
Effect of Metal Ions
A considerable amount of literature exists on the metal cofactor requirement of ALAD from different sources (22) (23) (24) (25) (26) (27) . The enzyme species are classified into five different types based on whether they require Zn 2ϩ (mammalian and yeast), Mg 2ϩ (plant, algae, and bacteria), or both (some bacteria). All the reported enzymes are inhibited by EDTA (26) or o-phenanthroline (24) and the inhibition can be overcome by the addition of Mg 2ϩ or Zn 2ϩ , depending on the enzyme species. Interesting results are obtained with rPfALAD in this regard. First of all, rPfALAD purified as described under "Experimental Procedures" and dialyzed extensively against 100 mM Tris buffer, pH 8.5, in the presence of 20% glycerol is active without addition of any metal ion. However, addition of Mg 2ϩ stimulates enzyme activity by 20 -30% at pH 8.5. As expected, the activity of rmALAD is not stimulated by Mg 2ϩ (Fig. 5A) . The unique features of rPfALAD are manifest in experiments studying the effects of EDTA and o-phenanthroline. EDTA does not inhibit rPfALAD enzyme activity even at 25 mM concentration and overnight treatment. Treatment of the enzyme with Chelex 100 resin does not lead to loss of enzyme activity (data not presented). RmALAD is inhibited to an extent of 90% at 5 mM EDTA concentration (Fig. 5B) .
Whereas EDTA does not inhibit the basal activity of rPfALAD, it inhibits the stimulation brought about by added Mg 2ϩ . o-Phenanthroline inhibits rmALAD activity by more than 90% at 0.5 mM concentration and this inhibition is substantially reversed in the presence of 20 -40 M Zn 2ϩ . rPfALAD activity is inhibited to 70% by o-phenanthroline at 5-10 mM concentration and this inhibition is not reversed in the presence of 10 -250 M Zn 2ϩ , either at pH 7.5 or 8.5. Interestingly, Mg 2ϩ stimulation of rPfALAD is seen with the untreated or o-phenanthroline-treated enzyme. It is concluded that the inhibitory effects of o-phenanthroline on PfALAD are not related to removal of any metal ion such as zinc. In fact, Zn 2ϩ as such is very inhibitory to rPfALAD activity. At pH 8.5, the enzyme activity is inhibited by 50% at 75 M Zn 2ϩ , and at pH 7.5 the metal is even more inhibitory, 50% inhibition being brought about by less than 20 M Zn 2ϩ . The 50% inhibitory value for rmALAD at pH 7.5 is around 120 M Zn 2ϩ (data not presented).
Effect of Monovalent Cation
rPfALAD activity is also stimulated by K ϩ and this activation is pH-dependent. Between pH 6.5 and 7.0, K ϩ is as stimulatory as Mg 2ϩ and the stimulation is almost 2-fold. However, while the stimulatory effect of Mg 2ϩ (around 20 -30%) is seen at all pH values tested (6.5-10) the effect of K ϩ wanes at pH values above 7 and is actually slightly inhibitory at pH 8.5 (Fig.  6) . It thus appears that K ϩ and Mg 2ϩ act at different sites on the enzyme. Atomic absorption spectrometric analysis of purified, enzymatically active rPfALAD that was dialyzed extensively against 100 mM Tris buffer, pH 8.5, containing 20% glycerol reveals that the enzyme contains 2 atoms of Mg 2ϩ per octamer of the enzyme.
Modeling of PfALAD Structure
ALAD asymmetrically condenses two molecules of ALA to produce PBG. The two ALA substrate molecules are distinguished as A-and P-site ALA because of the acetic acid and propionic acid side chains that they contribute to the product. The corresponding binding sites on ALAD are termed A-site and P-site, respectively. The sequence of PfALAD is structurally compatible with the TIM barrel-fold exhibited by all the other known structures of ALAD including the human enzyme (16, 28, 29) . It also contains the additional strands and helices located in a long extended N-terminal arm, as seen in other ALAD structures. The structure-based alignment of the amino acid sequence of PfALAD with PsALAD was carried out as described under "Experimental Procedures" (Fig. 7A) . A model of the octamer was constructed for PfALAD based on the arrangement seen in the PsALAD. Despite overall similarities in sequence, subunit, and quaternary structures between PfALAD and PsALAD, several fine differences exist. The sequence alignment of PfALAD with PsALAD reveals 3 single residue deletions and 6 short insertions spanning 1-4 residues distributed across the PfALAD primary structure. It is interesting to observe that 2 of the deletions and 3 of the insertions occur at the dimer-dimer interface such that the corresponding residues of the A subunit can interact with those of the E subunit. The insertion corresponding to residues 362-365 in PfALAD is an extended loop that projects toward the tetrameric axis stabilized by a salt-bridge formed by Lys 363 and Asp 365 present within the loop of each subunit. Because the octamer can be viewed as two tetramers stacking against each other, the extended loops of one tetramer stack against those of the other. Another insertion corresponding to residues 390 -392 is at the interface of two subunits forming a dimer.
Substrate Binding Sites-The residues in both the A-site as well as in the P-site are essentially identical in both enzymes, suggesting a mode of binding for the substrates similar to that in PsALAD, and indeed in all the other ALAD structures known so far. A series of events leading to the formation of a fully assembled active site (monomer A in dimer AB) has been proposed for PsALAD (17) . These are (a) entry of monovalent cation to the catalytic center that is then stabilized by is altered slightly because of the influence of an insertion at position 205 and a change in the amino acid sequence from position 218 to 221 in PfALAD; (b) the two adjacent residues, Asn 315 and Gln 317 , form bidentate hydrogen bonds in PfALAD that are absent in PsALAD; and (c) His 223 , which is in the vicinity of Lys 316 , keeps the Lys 316 fixed and oriented (to avoid charge repulsion) toward the substrate. PsALAD lacks this histidine and has Gln 138 in its place. Therefore, in PfALAD the positioning of the stretch from Lys 316 to Gln 320 seems to be prefixed because of the network of interactions highlighted (Fig. 7B) .
C-site Magnesium and Its Communication with the Active Site-Glu
245 in P. aeruginosa or its equivalent in plants is responsible for coordinating Mg 2ϩ at the C-site. In PfALAD, Glu 245 is replaced by Asn 331 and this change has been attributed earlier to a possible absence of C-site Mg 2ϩ binding in PfALAD (7) . However, an enhancement of catalysis in the presence of added Mg 2ϩ has been observed in the present study. Despite differences in amino acid residues at the C-site, energy minimization of the PfALAD model with magnesium docked into the site suggests that such a binding is energetically and geometrically feasible. In the PfALAD model, Asp (30, 31) , nitrogen donors such as in histidine imidazoles are also known to coordinate Mg 2ϩ (32, 33) . The other residues in the vicinity capable of coordinating Mg 2ϩ through water molecules are Arg 267 and His 321 (Fig. 7C ). Because the parasite is importing the hALAD, it is of interest to compare the geometry of the PfALAD substrate binding site with that of hALAD. Significant differences were observed because hALAD requires Zn 2ϩ for catalytic activity. 
Sensitivity to Succinylacetone
This inhibitor is specific for ALAD, although different ALAD species manifest differential sensitivity (24, 34) . The results presented in Fig. 8 reveal that rPfALAD and rmALAD are inhibited by succinylacetone, the latter being more sensitive than the former. Both enzymes are inhibited strikingly in the nanomolar range, 50% inhibition being brought about by 125 and 250 nM succinylacetone for rmALAD and rPfALAD, respectively. The host hALAD has also been partially purified and its succinyl acetone sensitivity is very similar to that of rmALAD.
Localization of ALAD in the Parasite
Studies were carried out to examine the localization of PfALAD in relation to that of the host enzyme in the parasite. Antibodies against the truncated protein rPf⌬ALAD react specifically with rPfALAD but not with the ALAD from human red blood cells in Western blot analysis. Antibodies to the human red blood cell ALAD are specific to the human enzyme (Fig. 9A) . The results presented in Fig. 9B reveal that both the host ALAD and PfALAD are detected in the parasite lysate. Although the concentration of the host ALAD in the parasite is significantly higher than that of PfALAD, exact quantification is not possible, because the blot has to be developed much longer to obtain the weaker signal for PfALAD. These results are also corroborated by the immunoelectron microscopic analysis of the infected red cell. The data presented in Fig. 10, A and B, reveal that host ALAD is widely distributed in the parasite cytoplasm and food vacuole. PfALAD signal is sparse, although its presence in the apicoplast can be clearly seen Fig.  10 , C and D. The distinctive four-membrane architecture that characterizes the apicoplast is reported to be fragile (35) . This is the first report on the actual detection of an enzyme of the heme-biosynthetic pathway in the apicoplast.
PfALAD and Host Enzyme Activity in the Parasite
It was of interest to assess the contribution of PfALAD to the total enzyme activity in the parasite, in view of the earlier reports from this laboratory on the import of the host enzyme into the parasite (2, 3). Having observed differential sensitivity of rPfALAD and rmALAD (as well as the native human red cell ALAD) to EDTA, the enzyme activities were assayed in the parasite lysate in the presence or absence of 25 mM EDTA. The results presented in Table I reveal that with total parasite extract the residual activity in the presence of EDTA is 13.8%, whereas the corresponding value for the host enzyme activity is 2.8%. Therefore, the contribution of PfALAD to the total ALAD activity in the parasite is around 11%.
DISCUSSION
The results obtained in the present study reveal that rPfALAD manifests properties expected of a plant-like enzyme species (alkaline pH optima and apicoplast localization), while at the same time manifesting certain unique properties such as Mg 2ϩ -independent and EDTA-resistant catalytic activity. Interestingly, the enzyme from P. aeruginosa has also been shown not to require any divalent metal ion for activity. The bacterial enzyme has been shown to contain 4 atoms of Mg 2ϩ , required for stabilizing the octameric structure but not essential for octamer formation or catalytic activity. This is the lowest number of bound, divalent metal ions yet reported for all species of ALAD except for rPfALAD, which is investigated in the present study. Hence, the enzyme from P. aeruginosa has been described as a novel type V ALAD (26, 36) . rPfALAD resembles the enzyme from P. aeruginosa in most of its properties, except in terms of sensitivity to EDTA and dialysis. The dialyzed enzyme is active in the absence of added metal ions per octamer, the significance of which is not clear at present. The Mg 2ϩ dependence of plant and algal ALADs in chloroplasts has been explained because of the presence of a high concentration of Mg 2ϩ (10 mM) that would help to overcome the thermodynamic difficulty of inserting Mg 2ϩ into protoporphyrin IX for chlorophyll biosynthesis. This perhaps acted as the evolutionary pressure against a chlorophyll biosynthetic enzyme such as ALAD, to switch over to Mg 2ϩ from Zn 2ϩ as the metal requirement (37) . Because, apicoplasts are held to be derived from algal plastids by secondary endosymbiosis (38) , PfALAD perhaps shows Mg 2ϩ dependence for activation. However, the concentration of Mg 2ϩ in the apicoplast is not known. The bacterial enzyme is completely inhibited by EDTA or just by dialysis and the apoenzyme can be reconstituted by Mg 2ϩ (26, 36) . The crystal structure of ALAD from P. aeruginosa reveals that Mg 2ϩ is bound 14 Å away from the Schiff base-forming nitrogen atom of the active site lysine (16) . Based on the crystal structure of the enzyme in complex with the inhibitor 5-fluorolevulinic acid at high resolution, the active site has been shown to contain a monovalent cation (Na ϩ ) that may assist in enzyme activity (17) . rPfALAD is similar to PsALAD in this regard and added K ϩ stimulates the enzyme activity in the pH range between 6.5 and 7.5. However, as stated earlier, rPfALAD unlike PsALAD does not lose enzyme activity on dialysis and is active in the absence of added Mg 2ϩ or K ϩ . Homology modeling studies were done to get insight into the unique properties of PfALAD discussed above. These studies have shown that the alterations in interactions arising out of the deletion and insertions in PfALAD, mentioned earlier, necessitate a minor reorientation of each subunit with respect to the others, as compared with that in PsALAD. In addition, there are a number of additional interactions between two dimers (e.g. A and E subunits of AB and EF dimers) in the PfALAD structure resulting in a stable octamer. The prefixed 
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a Total activity represents activity obtained from the soluble and membrane-bound enzyme extracted as given under "Experimental Procedures."
b rPfALAD was assayed in the absence of metal ions.
